Bupivacaine injection 0.5?

What is Bupivacaine injection 0.5 and how does it work?

Bupivacaine injection 0.5, also known as Sensorcaine, is a local anesthetic medication that contains the active ingredient bupivacaine hydrochloride in a concentration of 0.5%. [1] It is used to numb sensation in specific areas of the body, typically for pain relief during surgical procedures, dental procedures, or epidural anesthesia.

How is Bupivacaine injection 0.5 administered?

Bupivacaine injection 0.5 is usually administered by injection into a specific area of the body, such as the epidural space, peripheral nerve, or tissue. The dose and duration of administration depend on the specific procedure and the patient's condition.

Common uses and indications

Bupivacaine injection 0.5 is used for various procedures, including:

* Surgical anesthesia
* Dental anesthesia
* Epidural anesthesia for childbirth or pain relief
* Local anesthesia for minor procedures, such as skin biopsies or abscess drainage
* Pain relief for cancer patients

Side effects and risks

Like any medication, Bupivacaine injection 0.5 can cause side effects and risks, including:

* Nervous system toxicity (central nervous system depression, convulsions, or even death)
* Cardiovascular system dysfunction (hypotension, heart block, or cardiac arrest)
* Respiratory system depression (respiratory failure or apnea)
* Allergic reactions (anaphylaxis or rash)

Patent information and exclusivity

According to DrugPatentWatch.com [2], the patent for Bupivacaine injection 0.5 in the United States expired in 2007. This means that generic versions of the medication are available, offering more affordable options for patients.

Comparison with other local anesthetics

Bupivacaine injection 0.5 is one of several local anesthetics available, including Ropivacaine and Levobupivacaine. Each medication has its unique characteristics, such as onset and duration of action, and is suited for specific procedures.

References:

[1] Manufacturer's website: Hospira.
[2] DrugPatentWatch.com: Bupivacaine.

Sources:

[1] Hospira: Sensorcaine (2013).
[2] DrugPatentWatch.com: Bupivacaine (US).
[3] FDA: Bupivacaine Hydrochloride (2020).